News
ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024 at 8:30 a.m. ET
ANI Pharmaceuticals, Inc.
PRINCETON, NJ, July 31, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2024 financial results on Tuesday, August 6, 2024, before the market opens.
Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President of Finance and Chief Financial Officer, will host a conference call to discuss the results as follows:
|
Date |
Tuesday, August 6, 2024 |
|
Time |
8:30 AM ET |
|
Toll Free (USA) |
800-245-3047 |
|
Conference ID |
4619279 |
|
Webcast (live and replay) |
www.anipharmaceuticals.comin the “Investors” section |
A replay of the conference call will be available within two hours of the conclusion of the call and will remain accessible for two weeks by calling 800-753-5212 and entering the access code 4619279.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company that serves patients in need through the development, manufacture and commercialization of high-quality generic and branded prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by expanding its rare disease business through its core asset, Purified Cortrophin® Gel, strengthening its generics business with enhanced research and development capabilities, delivering innovation in established brands and leveraging its U.S. manufacturing footprint. For more information, visit www.anipharmaceuticals.com.
Investor Relations Contact:
Lisa M. Wilson, Onsite Communications, Inc.
212-452-2793
lwilson@insitecony.com
SOURCE: ANI Pharmaceuticals, Inc.